← FDA Drug Approvals (Drugs@FDA)
PROGESTERONE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACCORD HLTHCARE · Approved 2023-11-21
Drug application
- FDA Application #
ANDA217707- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- PROGESTERONE
- Generic name
- Progesterone
- Active ingredients
- PROGESTERONE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Discontinued
- Sponsor
- ACCORD HLTHCARE
- First approval
- 2023-11-21
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown